Vericel to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 26, 2026
Rhea-AI Summary
Vericel (NASDAQ:VCEL) will report fourth-quarter and full-year 2025 financial results on Thursday, February 26, 2026.
Management will host a conference call and webcast at 8:30 a.m. ET. Presentation slides will be available on the Investor Relations website and a replay will be available through February 26, 2027. Telephone participants may dial 800-330-6730 or +1-312-471-1351 with passcode 227995.
Positive
- None.
Negative
- None.
News Market Reaction – VCEL
In the Feb 12 session, VCEL declined 1.91%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 13 | Prelim 2025 results | Positive | +1.3% | Preliminary 2025 revenue, margin and cash updates ahead of full results. |
| Jan 06 | JPM conference presentation | Positive | +6.1% | Announcement of presentation at 44th Annual J.P. Morgan Healthcare Conference. |
| Nov 14 | Stephens conference appearance | Positive | +0.1% | Fireside chat at Stephens Investment Conference with webcast access for investors. |
| Nov 06 | Q3 2025 earnings | Positive | +4.2% | Record Q3 revenue, strong MACI growth, profitability and reaffirmed 2025 guidance. |
| Oct 23 | Earnings date announcement | Neutral | -1.2% | Scheduling of Q3 2025 earnings call and webcast with replay details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news — especially earnings and financial updates — has typically seen the stock move in the same direction as the news tone, with positive fundamentals followed by positive price reactions.
Over the last few months, Vericel has delivered a series of positive fundamental updates. On Nov 6, 2025, record Q3 2025 earnings with $67.5M revenue and solid profitability coincided with a 4.17% gain. Preliminary 2025 results on Jan 13, 2026 highlighted ~$276M revenue and strong margins, with a 1.26% rise. Conference appearances in November 2025 and January 2026 also saw modest to strong gains. A prior earnings date announcement on Oct 23, 2025 had a small negative move, but overall reactions have aligned with generally constructive news.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its fourth-quarter and full-year 2025 financial results on Thursday, February 26, 2026. Vericel’s management will host a conference call and webcast at 8:30 a.m. ET to discuss its financial results and business highlights.
The live webcast can be accessed on the Investor Relations section of the Vericel website at http://investors.vcel.com/events-presentations. Presentation slides for the conference call will be available on the webcast and on the website. A replay of the webcast will be available until February 26, 2027.
To participate by telephone, dial 800-330-6730 or +1-312-471-1351 if connecting from outside the U.S. When connected, please use passcode: 227995.
About Vericel Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to
Investor Contact:
Eric Burns
ir@vcel.com
+1 (734) 418-4411
